Esperion Therapeutis.Inc. buy Wolf_of_WS
Summary
This prediction ended on 01.10.23 with a price of €0.94. With a performance of -7.27%, the BUY prediction for Esperion Therapeutis.Inc. by Wolf_of_WS closed slightly in the red. Wolf_of_WS has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Esperion Therapeutis.Inc. | -1.487% | -1.487% |
iShares Core DAX® | 0.393% | -4.045% |
iShares Nasdaq 100 | 0.394% | -8.892% |
iShares Nikkei 225® | 1.038% | -9.388% |
iShares S&P 500 | -0.046% | -4.765% |
According to Wolf_of_WS what are the pros and cons of Esperion Therapeutis.Inc. for the foreseeable future?
Pros
Cons
Comments by Wolf_of_WS for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
In the thread Trading Esperion Therapeutis.Inc.
Stopped prediction by Wolf_of_WS for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
23.08.23
23.08.24
30.08.23
Esperion Therapeutis.Inc.
10.05.23
10.05.24
15.05.23
Esperion Therapeutis.Inc.
11.04.23
11.04.24
15.04.23